en

PRODUCT DETAIL

Pazopanib Teva 400 mg filmom obalené tablety

Code 9688D
MA number 44/0038/22-S
Product Form: tbl flm 60(2x30)x400 mg (blis.Al/PVC/PE/PVDC-multibal.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: Teva B.V., Netherland
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EX Other protein kinase inhibitors
L01EX03 Pazopanib
Shelf life: 36
Container: blister Al/PVC/PE/PVDC
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 28.02.2022
Validity: 28.02.2027
Pediatric warnings: Yes
PIL: PIL_Pazopanib Teva 02_2022.pdf  
SPC: SPC_Pazopanib Teva 400 mg filmom obalené tablety_04.2023.pdf  
Safety feature Yes
Data update: 14.04.2023
eu-flag.png sk-flag.png